BridgeMD
New treatment option for Hypercholesterolemia
Official title Effect of Two Food Supplements on Lipid Profile in Patients With Mild Hypercholesterolemia
ClinicalTrials.gov ID: NCT07295327
What this study is testing
- What it's testing
- The primary outcome is to evaluate the effect of Cynacol on the change in LDL-C levels compared to Metacol after 90 days of supplementation. The secondary outcomes are to evaluate: \- the change of TC, non-HDL cholesterol (non-HDL-C), apolipoprotein B (apoB), Tg, HDL-C levels after 90 days of supplementation with Cynacol compared to Metacol.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 70
You may be able to join if
- age between 35-70 years
- both genders
- LDL-C levels between 115 and 190 mg/dl
- people able to understand the informed consent and sign it before enrollment in the study
You likely can't join if
- personal history of cardiovascular disease or equivalent risk factors
- Tg levels ≥ 400 mg/dl
- obesity [body mass index (BMI) ≥ 30 kg/m²]
- taking hypolipidemic drugs or supplements that affect lipid metabolism
- diabetes mellitus
- known thyroid, liver, kidney or muscle diseases
See the full eligibility criteria
- age between 35-70 years
- both genders
- LDL-C levels between 115 and 190 mg/dl
- people able to understand the informed consent and sign it before enrollment in the study
- personal history of cardiovascular disease or equivalent risk factors
- Tg levels ≥ 400 mg/dl
- obesity [body mass index (BMI) ≥ 30 kg/m²]
- taking hypolipidemic drugs or supplements that affect lipid metabolism
- diabetes mellitus
- known thyroid, liver, kidney or muscle diseases
- any medical or surgical condition that makes patient compliance with the study protocol complex or inconsistent
- any known allergy or hypersensitivity to one or more components of the food supplements
The study team makes the final eligibility decision.
Where it's taking place
- Pavia, Lombardy, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pavia, Lombardy, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.